Report: J&J nearing hip settlement

Share this article:

Johnson & Johnson may be nearing a settlement over hip replacements manufactured by its DePuy subsidiary. The New York Times reports that the company may agree to pay out close to $4 billion over the Articular Surface Replacement hips which shed metal fragments in patients as the devices wore down.

The New York Times says the number has to be approved by the court and the total could change, since the number of eligible patients has to be determined. The current estimate is that a settlement could affect 7,000 to 8,000 patients.

The company has been taking an increasing amount of heat over the faulty hip replacements: as noted by the Times the hips were not just faulty, but company documents show the subsidiary knew there were problems with the design.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.